Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy

• Sabrina Ritscher ,

  Roles Investigation, Methodology, Validation, Writing – original draft

  * E-mail: ritscher@med.uni-frankfurt.de

  Affiliation Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital, Goethe University, Frankfurt/Main, Germany

  http://orcid.org/0000-0002-6718-2692

  ⨯
• Milena Hoyer,

  Roles Supervision

  Affiliation Department of Nephrology, Medical Clinic III, University Hospital, Goethe University, Frankfurt/Main, Germany

  ⨯
• Coralie Georges,

  Roles Supervision

  Affiliation Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

  ⨯
• Cora Wunder,

  Roles Conceptualization, Validation

  Affiliation Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital, Goethe University, Frankfurt/Main, Germany

  ⨯
• Pierre Wallemacq,

  Roles Supervision

  Affiliations Clinical Chemistry Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium

  ⨯
• Alexandre Persu,

  Roles Supervision, Writing – review & editing

  Affiliations Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium, Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium

  ⨯
• Nicholas Obermüller,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Nephrology, Medical Clinic III, University Hospital, Goethe University, Frankfurt/Main, Germany

  ⨯
• Stefan W. Toennes

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital, Goethe University, Frankfurt/Main, Germany

  ⨯